IBDEI0PK ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,11405,1,3,0)
 ;;=3^Primary Open-Angle Gluacoma,Mod Stage,Bilateral
 ;;^UTILITY(U,$J,358.3,11405,1,4,0)
 ;;=4^H40.1132
 ;;^UTILITY(U,$J,358.3,11405,2)
 ;;=^5138548
 ;;^UTILITY(U,$J,358.3,11406,0)
 ;;=H40.1232^^77^732^19
 ;;^UTILITY(U,$J,358.3,11406,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11406,1,3,0)
 ;;=3^Low-Tension Glaucoma,Mod,Bilateral
 ;;^UTILITY(U,$J,358.3,11406,1,4,0)
 ;;=4^H40.1232
 ;;^UTILITY(U,$J,358.3,11406,2)
 ;;=^5005769
 ;;^UTILITY(U,$J,358.3,11407,0)
 ;;=H40.1113^^77^732^12
 ;;^UTILITY(U,$J,358.3,11407,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11407,1,3,0)
 ;;=3^Primary Open-Angle Glaucoma,Sev Stage,Right Eye
 ;;^UTILITY(U,$J,358.3,11407,1,4,0)
 ;;=4^H40.1113
 ;;^UTILITY(U,$J,358.3,11407,2)
 ;;=^5138539
 ;;^UTILITY(U,$J,358.3,11408,0)
 ;;=H40.1123^^77^732^13
 ;;^UTILITY(U,$J,358.3,11408,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11408,1,3,0)
 ;;=3^Primary Open-Angle Glaucoma,Sev Stage,Left Eye
 ;;^UTILITY(U,$J,358.3,11408,1,4,0)
 ;;=4^H40.1123
 ;;^UTILITY(U,$J,358.3,11408,2)
 ;;=^5138544
 ;;^UTILITY(U,$J,358.3,11409,0)
 ;;=H40.022^^77^732^24
 ;;^UTILITY(U,$J,358.3,11409,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11409,1,3,0)
 ;;=3^Open Angle w/ Borderline Findings,High Risk,Left Eye
 ;;^UTILITY(U,$J,358.3,11409,1,4,0)
 ;;=4^H40.022
 ;;^UTILITY(U,$J,358.3,11409,2)
 ;;=^5005729
 ;;^UTILITY(U,$J,358.3,11410,0)
 ;;=H40.021^^77^732^23
 ;;^UTILITY(U,$J,358.3,11410,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11410,1,3,0)
 ;;=3^Open Angle w/ Borderline Findings,High Risk,Right Eye
 ;;^UTILITY(U,$J,358.3,11410,1,4,0)
 ;;=4^H40.021
 ;;^UTILITY(U,$J,358.3,11410,2)
 ;;=^5005728
 ;;^UTILITY(U,$J,358.3,11411,0)
 ;;=H40.1131^^77^732^8
 ;;^UTILITY(U,$J,358.3,11411,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11411,1,3,0)
 ;;=3^Primary Open-Angle Glaucoma,Mild Stage,Bilateral
 ;;^UTILITY(U,$J,358.3,11411,1,4,0)
 ;;=4^H40.1131
 ;;^UTILITY(U,$J,358.3,11411,2)
 ;;=^5138547
 ;;^UTILITY(U,$J,358.3,11412,0)
 ;;=H40.1112^^77^732^9
 ;;^UTILITY(U,$J,358.3,11412,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11412,1,3,0)
 ;;=3^Primary Open-Angle Glaucoma,Mod Stage,Right Eye
 ;;^UTILITY(U,$J,358.3,11412,1,4,0)
 ;;=4^H40.1112
 ;;^UTILITY(U,$J,358.3,11412,2)
 ;;=^5138538
 ;;^UTILITY(U,$J,358.3,11413,0)
 ;;=H40.1122^^77^732^10
 ;;^UTILITY(U,$J,358.3,11413,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11413,1,3,0)
 ;;=3^Primary Open-Angle Glaucoma,Mod Stage,Left Eye
 ;;^UTILITY(U,$J,358.3,11413,1,4,0)
 ;;=4^H40.1122
 ;;^UTILITY(U,$J,358.3,11413,2)
 ;;=^5138543
 ;;^UTILITY(U,$J,358.3,11414,0)
 ;;=H40.1114^^77^732^14
 ;;^UTILITY(U,$J,358.3,11414,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11414,1,3,0)
 ;;=3^Primary Open-Angle Glaucoma,Indeterminate,Right Eye
 ;;^UTILITY(U,$J,358.3,11414,1,4,0)
 ;;=4^H40.1114
 ;;^UTILITY(U,$J,358.3,11414,2)
 ;;=^5138540
 ;;^UTILITY(U,$J,358.3,11415,0)
 ;;=H40.1124^^77^732^15
 ;;^UTILITY(U,$J,358.3,11415,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11415,1,3,0)
 ;;=3^Primary Open-Angle Glaucoma,Indeterminate,Left Eye
 ;;^UTILITY(U,$J,358.3,11415,1,4,0)
 ;;=4^H40.1124
 ;;^UTILITY(U,$J,358.3,11415,2)
 ;;=^5138545
 ;;^UTILITY(U,$J,358.3,11416,0)
 ;;=Z83.511^^77^732^26
 ;;^UTILITY(U,$J,358.3,11416,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11416,1,3,0)
 ;;=3^Family Hx of Glaucoma
 ;;^UTILITY(U,$J,358.3,11416,1,4,0)
 ;;=4^Z83.511
 ;;^UTILITY(U,$J,358.3,11416,2)
 ;;=^5063382
